MRK
25
-2
XYL
49
4
CMA
61
5
HD
57
2
RIG
60
2
JPM
69
2
ES
34
3
CFG
70
6
MAS
58
2
HST
49
-9
SYY
53
4
CF
57
-2
CPB
30
6
WBA
48
4
ROST
63
12
GS
75
2
PRGO
39
3
TJX
64
2
UNP
52
7
FE
50
-2
MRK
25
-2
XYL
49
4
CMA
61
5
HD
57
2
RIG
60
2
JPM
69
2
ES
34
3
CFG
70
6
MAS
58
2
HST
49
-9
SYY
53
4
CF
57
-2
CPB
30
6
WBA
48
4
ROST
63
12
GS
75
2
PRGO
39
3
TJX
64
2
UNP
52
7
FE
50
-2
Financhill
Back

Bicara Therapeutics Vs. Kairos Pharma Industry Stock Comparison

Sell
20

BCAX
Bicara Therapeutics

Last Price:
18.08
Seasonality Move:
--
Sell
14

KAPA
Kairos Pharma

Last Price:
1.61
Seasonality Move:
--
Sell
20
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $18.09. The Score for BCAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
14
Kairos Pharma (KAPA) is a Sell

Is Kairos Pharma a Buy, Sell or Hold?

  • The current Kairos Pharma [KAPA] share price is $1.60. The Score for KAPA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • KAPA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $18.09
    The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.

KAPA Stock Price Chart

What is Kairos Pharma's stock price today?

  • The Kairos Pharma share price today is $1.60
    The current trend is relatively stagnant and KAPA is experiencing slight selling pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.37 Sell
Chaikin Money Flow: -17151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 24.31) Sell
Bollinger Bands (100): ( - ) Buy

KAPA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 49.3 Sell
Chaikin Money Flow: -44456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.27 - 1.75) Buy
Bollinger Bands (100): ( - ) Buy

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.65 Sell
20-day SMA: 22.12 Sell
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 19.51 Sell
20-day EMA: 20.67 Sell
50-day EMA: 17.42 Buy
200-day EMA: 7.31 Buy

KAPA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.69 Sell
20-day SMA: 1.52 Buy
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 1.59 Buy
20-day EMA: 1.53 Buy
50-day EMA: 1.21 Buy
200-day EMA: 0.49 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.

Kairos Pharma Earnings Growth & KAPA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kairos Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):